U
MDT icon

UBS’s Medtronic MDT Stock Holding History

UBS’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$10.5M Buy
169,400
+142,371
+527% +$9.05M 0.01% 1414
2014
Q2 		$1.72M Buy
27,029
+21,729
+410% +$1.32M ﹤0.01% 3013
2014
Q1 		$326K Sell
5,300
-44,300
-89% -$2.58M ﹤0.01% 4681
2013
Q4 		$2.85M Buy
49,600
+15,300
+45% +$868K ﹤0.01% 2453
2013
Q3 		$1.83M Buy
34,300
+2,900
+9% +$156K ﹤0.01% 2687
2013
Q2 		$1.62M Buy
+31,400
New +$1.55M ﹤0.01% 2789

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS's MDT Position: Q3 2014 in Review

UBS increased its Medtronic (MDT) stake by 0.5% in Q3 2014, buying an estimated $2.48M and bringing the position to 7,777,927 shares worth $482M. The position accounts for 0.36% of the portfolio, ranked #43.

UBS first reported a position in MDT in Q2 2013 and has held it in 6 quarters since. The position peaked at $493M in Q2 2014. 1,135 funds tracked by Wall St. Rank hold MDT as of Q3 2014.

  • UBS held 7,777,927 shares of Medtronic worth $482M as of Q3 2014.
  • UBS bought 39,070 Medtronic shares in Q3 2014, an estimated $2.48M.
  • Medtronic made up 0.36% of UBS's portfolio in Q3 2014, its #43 holding.
  • UBS first reported a position in Medtronic in Q2 2013 and has held it in 6 quarters since.
  • UBS's Medtronic position peaked at $493M in Q2 2014.
  • 1,135 funds tracked by Wall St. Rank held Medtronic as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.